# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.
Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor...
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that a post hoc analysis of clinical data from its inTandem3 Phase ...
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08%...